Page 58 - Educacional Ponenecias Congreso SEHH-STH 2020

6. Bowman Z, Fei N, Ahn J, Wen S, Cumpston A, Shah N, et al. Single versus double-unit transfusion: safety and efficacy for patients with hematologic malignancies. Eur J Haematol. 2019;102(5):383-8.
7. Warner MA, Jambhekar NS, Saadeh S, Jacob EK, Kreuter JD, Mundell WC, et al. Implementation of a patient blood management program in hema- topoietic stem cell transplantation (Editorial, p. 2763). Transfusion. 2019 Sep;59(9):2840-8.
8. Davis BA, Allard S, Qureshi A, Porter JB, Pancham S, Win N, et al. British Com- mittee for Standards in Haematology. (2017). Guidelines on red cell trans- fusion in sickle cell disease. Part I: principles and laboratory aspects. Br J Haematol. 2017;176(2):179-91.
9. Kotzé A, Harris A, Baker C, Iqbal T, Lavies N, Richards T, et al. British committee for standards in haematology guidelines on the identifica- tion and management of pre-operative anaemia. Br J Haematol. 2015 Nov;171(3):322-31.
10. Trompeter S, Massey E, Robinson S; Transfusion Task Force of the British Society of Haematology Guidelines Committee. Position paper on Interna- tional Collaboration for Transfusion Medicine (ICTM) Guideline ‘Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline’. Br J Haematol. 2020;189(3):424-7.
11. Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016 Jan;172(2):187-207.
12. Davis BA, Allard S, Qureshi A, Porter JB, Pancham S, Win N, et al.; British Soci- ety for Haematology. Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion. Br J Haematol. 2017 Jan;176(2):192-209.
13. Estcourt LJ, Fortin PM,Trivella M, Hopewell S. Preoperative blood transfusions for sickle cell disease. Cochrane Database Syst Rev. 2016;4(4):CD003149.
14. Neoh K, Gray R, Grant-Casey J, Estcourt L, Malia C, Boland JW, Bennett MI. Na- tional comparative audit of red blood cell transfusion practice in hospices: Rec- ommendations for palliative care practice. Palliat Med. 2019 Jan;33(1):102-8.
15. Odejide OO, Steensma DP. Patients with haematological malignancies should not have to choose between transfusions and hospice care. Lancet Haematol. 2020;7(5):e418-e424.
16. Chhetri R, Wee A, Sinha R, Kutyna MM, Gupta S, Nath L, et al. Red Cell Alloimmunisation Is Associated with Increased Red Cell Transfusion Re-
quirements in Myelodysplastic Syndrome. Blood. 2018;132(Supplement
1):1826.
17. Cohen D, Hartung H, Evans P, Friedman DF, Chou ST. Red blood cell alloimmu-
nization in transfused patients with bone marrow failure syndromes.Transfu-
sion. 2016;56(6):1314-9.
18. Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, et al. The Co-
operative Study of Sickle Cell Disease Transfusion and alloimmunization in
sickle cell disease. Blood. 1990;76(7):1431-7.
19. Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, et al.
American Society of Hematology 2020 guidelines for sickle cell disease:
transfusion support. Blood Adv. 2020;4(2):327-55.
20. Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S. A ther-
apeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. 2015;9(9):CD010981.
21. Malouf R, Ashraf A, Hadjinicolaou AV, Doree C, Hopewell S, Estcourt LJ. Com- parison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. Co- chrane Database Syst Rev. 2018;5(5):CD012342.
22. Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF. Com- parison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with hae- matological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. 2015;11(11):CD010983.
23. Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, Murphy MF. Different doses of prophylactic platelet transfusion for preventing bleed- ing in people with haematological disorders after myelosuppressive chemo- therapy or stem cell transplantation. Cochrane Database Syst Rev. 2015 Oct 27;10(10):CD010984.
24. Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, et al. Guidelines for the use of platelet transfusions. Br J Haematol. 2017 Feb;176(3):365-94. 25. Green L, Bolton-Maggs P, Beattie C, Cardigan R, Kallis Y, Stanworth SJ, et al. Brit- ish Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups
in the absence of major bleeding. Br J Haematol. 2018 Apr;181(1):54-67.
LXII Congreso Nacional de la Sociedad Española de Hematología y Hemoterapia / Ponencias
58